Literature DB >> 11247813

GRK3 mediates desensitization of CRF1 receptors: a potential mechanism regulating stress adaptation.

F M Dautzenberg1, S Braun, R L Hauger.   

Abstract

Potential G protein-coupled receptor kinase (GRK) and protein kinase A (PKA) mediation of homologous desensitization of corticotropin-releasing factor type 1 (CRF1) receptors was investigated in human retinoblastoma Y-79 cells. Inhibition of PKA activity by PKI(5-22) or H-89 failed to attenuate homologous desensitization of CRF1 receptors, and direct activation of PKA by forskolin or dibutyryl cAMP failed to desensitize CRF-induced cAMP accumulation. However, treatment of permeabilized Y-79 cells with heparin, a nonselective GRK inhibitor, reduced homologous desensitization of CRF1 receptors by approximately 35%. Furthermore, Y-79 cell uptake of a GRK3 antisense oligonucleotide (ODN), but not of a random or mismatched ODN, reduced GRK3 mRNA expression by approximately 50% without altering GRK2 mRNA expression and inhibited homologous desensitization of CRF1 receptors by approximately 55%. Finally, Y-79 cells transfected with a GRK3 antisense cDNA construct exhibited an approximately 50% reduction in GRK3 protein expression and an ~65% reduction in homologous desensitization of CRF1 receptors. We conclude that GRK3 contributes importantly to the homologous desensitization of CRF1 receptors in Y-79 cells, a brain-derived cell line.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11247813     DOI: 10.1152/ajpregu.2001.280.4.R935

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  18 in total

Review 1.  Molecular and cell signaling targets for PTSD pathophysiology and pharmacotherapy.

Authors:  Richard L Hauger; J Alberto Olivares-Reyes; Frank M Dautzenberg; James B Lohr; Sandra Braun; Robert H Oakley
Journal:  Neuropharmacology       Date:  2011-11-25       Impact factor: 5.250

2.  Desensitization of human CRF2(a) receptor signaling governed by agonist potency and βarrestin2 recruitment.

Authors:  Richard L Hauger; J Alberto Olivares-Reyes; Sandra Braun; Judith Hernandez-Aranda; Christine C Hudson; Eric Gutknecht; Frank M Dautzenberg; Robert H Oakley
Journal:  Regul Pept       Date:  2013-06-29

Review 3.  Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: new molecular targets.

Authors:  Richard L Hauger; Victoria Risbrough; Olaf Brauns; Frank M Dautzenberg
Journal:  CNS Neurol Disord Drug Targets       Date:  2006-08       Impact factor: 4.388

4.  Ro 32-0432 attenuates mecamylamine-precipitated nicotine withdrawal syndrome in mice.

Authors:  Thakur Gurjeet Singh; Ashish K Rehni; Sandeep Arora
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-12-29       Impact factor: 3.000

Review 5.  New mechanisms and perspectives in nicotine withdrawal.

Authors:  K J Jackson; P P Muldoon; M De Biasi; M I Damaj
Journal:  Neuropharmacology       Date:  2014-11-26       Impact factor: 5.250

Review 6.  Role of CRF receptor signaling in stress vulnerability, anxiety, and depression.

Authors:  Richard L Hauger; Victoria Risbrough; Robert H Oakley; J Alberto Olivares-Reyes; Frank M Dautzenberg
Journal:  Ann N Y Acad Sci       Date:  2009-10       Impact factor: 5.691

7.  Leukocyte analysis from WHIM syndrome patients reveals a pivotal role for GRK3 in CXCR4 signaling.

Authors:  Karl Balabanian; Angélique Levoye; Lysiane Klemm; Bernard Lagane; Olivier Hermine; Julie Harriague; Françoise Baleux; Fernando Arenzana-Seisdedos; Françoise Bachelerie
Journal:  J Clin Invest       Date:  2008-03       Impact factor: 14.808

8.  Decreased GRK3 but not GRK2 expression in frontal cortex from bipolar disorder patients.

Authors:  Jagadeesh S Rao; Stanley I Rapoport; Hyung-Wook Kim
Journal:  Int J Neuropsychopharmacol       Date:  2009-04-29       Impact factor: 5.176

Review 9.  Using high resolution imaging to determine trafficking of corticotropin-releasing factor receptors in noradrenergic neurons of the rat locus coeruleus.

Authors:  B A S Reyes; D A Bangasser; R J Valentino; E J Van Bockstaele
Journal:  Life Sci       Date:  2014-07-21       Impact factor: 5.037

10.  Identification of brain target neurons using a fluorescent conjugate of corticotropin-releasing factor.

Authors:  Catherine S Hubbard; E Kurt Dolence; Joel A Shires; James D Rose
Journal:  J Chem Neuroanat       Date:  2009-02-07       Impact factor: 3.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.